PetVivo Holdings, Inc. has disclosed recent stock transactions involving its Chief Financial Officer, Garry Lowenthal. This filing is significant as it reflects the company's ongoing commitment to transparency and active management participation.
Background
PetVivo Holdings, Inc. operates within the surgical and medical instruments and apparatus sector, classified under SIC code 3841. The company is traded on the OTC exchange under the ticker symbol PETV. As an emerging growth company, PetVivo has been actively filing various reports, including recent Form 4 filings on October 23, 2026.
What the Filing Says
According to the filing dated October 23, 2026, Lowenthal reported two transactions involving the company's common stock. On October 21, he acquired 10,000 shares at a price of $0.68 per share, bringing his total ownership to 995,131 shares. Subsequently, on October 23, he disposed of 7,500 shares at the same price, reducing his holdings to 987,631 shares. The filing notes that the acquisition was a grant of restricted stock as compensation for past performance, while the disposal was made pursuant to a Stock Transfer Agreement.
Impact
This update may affect current and potential investors by providing insights into the management's confidence in the company's future. It also highlights the importance of transparency in corporate governance, especially in the surgical and medical instruments industry, where trust and credibility are crucial.
What's Next
The filing does not say what happens next.